MORTIMER IAN (PRESIDENT & CFO) sold 26.8% of their position (7.31K shares) of XENON PHARMACEUTICALS INC. on the open market
Open‑market sale worth $403.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/13/2026ACC: 0001193125-26-106724
Officer· PRESIDENT & CFO
Since Sep 2019
-7.31K
Net shares
Net seller
$403.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
12.50K acquired · 19.81K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+12.50K
Price / share
—
Trade value
—
% of position
84.9%
3/12/2026
14.73K→27.23K
Common Shares
Direct
Shares
−7.31K
Price / share
$55.23
Trade value
$403.58K
% of position
26.8%
3/13/2026
27.23K→19.92K
Total
Net shares
+5.19K
Net value
-$403.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 3/12/2026 | M · Option Exercise | +12.50K | — | — | 84.9% | 14.73K | 27.23K |
| Common Shares Direct | 3/13/2026 | S · Sale | −7.31K | $55.23 | $403.58K | 26.8% | 27.23K | 19.92K |
| Total | +5.19K | -$403.58K | ||||||
Derivative Transactions1
Restricted Share Units
Direct
Converts to
Common Shares
12.50K shares
Shares
−12.50K
Strike price
Held after
37.50K
Exercisable
—
3/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Common Shares12.50K shares | 3/12/2026 | M · Option Exercise | −12.50K | — | 37.50K |
Non-Derivative Holdings (Post-Transaction)1
Common Shares
IndirectShares owned14.30K
Total
14.30K indirect14.30K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 14.30K | Indirect |
| Total | 14.30K | 14.30K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported